Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study by Nianmin Shi, Anvar Rasuli, Yaël Thollot

Connect to this object online.

Clinical experience with the inactivated hepatitis A vaccine, Avaxim 80U Pediatric by Catherine Bravo, Larissa Mege, Claire Vigne, Yael Thollot

Connect to this object online.

Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina by Carlos Espul, Laura Benedetti, Mariela Linares, Hector Cuello, Ivana Lo Castro, Yaël Thollot, Anvar Rasuli

Connect to this object online.

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C... by Markus Knuf, Mika Rämet, Nina Breinholt Stærke, Isabelle Bertrand-Gerentes, Yaël Thollot, Siham B'Chir, Habiba Arroum, Philipp Oster

Connect to this object online.

Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial by Lina Cordero De Los Santos, Jesús Feris-Iglesias, Naveena Aloysia D'Cor, Venkata Jayanth Midde, Badri Narayan Patnaik, Yaël Thollot, Anvar Rasuli, Eric Desauziers

Connect to this object online.

Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines by Maria Rosario Z. Capeding, Maria Liza Antoinette M. Gonzales, Mandeep Singh Dhingra, Naveena Aloysia D'Cor, Venkat Jayanth Midde, Badri Narayan Patnaik, Yaël Thollot, Eric Desauziers

Connect to this object online.